Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
J Am Geriatr Soc. 2020 Apr;68(4):746-753. doi: 10.1111/jgs.16370. Epub 2020 Feb 17.
Shared decision making is essential to deprescribing unnecessary or harmful medications in older adults, yet patients' and caregivers' perspectives on medication value and how this affects their willingness to discontinue a medication are poorly understood. We sought to identify the most significant factors that impact the perceived value of a medication from the perspective of patients and caregivers.
Qualitative study using focus groups conducted in September and October 2018.
Participants from the Pepper Geriatric Research Registry (patients) and the Pitt+Me Registry (caregivers) maintained by the University of Pittsburgh.
Six focus groups of community-dwelling adults aged 65 years or older, or their caregivers, prescribed five or more medications in the preceding 12 months.
We sought to identify (1) general views on medication value and what makes medication worth taking; (2) how specific features such as cost or side effects impact perceived value; and (3) reactions to clinical scenarios related to deprescribing.
We identified four themes. Perceived effectiveness was the primary factor that caused participants to consider a medication to be of high value. Participants considered a medication to be of low value if it adversely affected quality of life. Participants also cited cost when determining value, especially if it resulted in material sacrifices. Participants valued medications prescribed by providers with whom they had good relationships rather than valuing level of training. When presented with clinical scenarios, participants ably weighed these factors when determining the value of a medication and indicated whether they would adhere to a deprescribing recommendation.
We identified that perceived effectiveness, adverse effects on quality of life, cost, and a strong relationship with the prescriber influenced patients' and caregivers' views on medication value. These findings will enable prescribers to engage older patients in shared decision making when deprescribing unnecessary medications and will allow health systems to incorporate patient-centered assessment of value into systems-based deprescribing interventions. J Am Geriatr Soc 68:746-753, 2020.
在老年人中,共同决策对于减少不必要或有害的药物至关重要,但患者和护理人员对药物价值的看法以及这如何影响他们停止用药的意愿仍知之甚少。我们试图从患者和护理人员的角度确定影响药物感知价值的最重要因素。
2018 年 9 月和 10 月进行的定性研究,使用焦点小组。
匹兹堡大学维护的胡椒老年研究注册处(患者)和皮特+我注册处(护理人员)的参与者。
6 个焦点小组,由 65 岁或以上的社区居住成年人或他们的护理人员组成,在过去 12 个月内服用了 5 种或更多药物。
我们试图确定(1)对药物价值的一般看法以及使药物值得服用的原因;(2)成本或副作用等特定特征如何影响感知价值;(3)与减少药物相关的临床情况的反应。
我们确定了四个主题。感知有效性是导致参与者认为药物具有高价值的主要因素。如果药物对生活质量产生不利影响,参与者认为药物价值较低。参与者在确定价值时还提到了成本,特别是如果这导致物质牺牲。参与者重视与他们建立良好关系的提供者开的药物,而不是重视培训水平。当出现临床情况时,参与者能够在确定药物价值时权衡这些因素,并表明他们是否会坚持减少药物的建议。
我们发现感知有效性、对生活质量的不利影响、成本和与开处方者的牢固关系影响了患者和护理人员对药物价值的看法。这些发现将使开处方者能够在减少不必要的药物时与老年患者进行共同决策,并使卫生系统将以患者为中心的价值评估纳入基于系统的减少药物干预措施中。美国老年医学会杂志 68:746-753,2020 年。